
Masahisa Jinushi
I start my carrier as a gastroenterologist and get PhD at Osaka University where I studied molecular... | Japan
*50 free lookup(s) per month.
No credit card required.
Masahisa Jinushi’s Emails ma****@gi****.com
Masahisa Jinushi’s Phone Numbers No phone number available.
Social Media
Masahisa Jinushi’s Location Japan
Masahisa Jinushi’s Expertise I start my carrier as a gastroenterologist and get PhD at Osaka University where I studied molecular mechanisms of HCV immunoevasion. I also focused on cancer immunotherapy at Dana-Farber Cancer Institute from 2004 to 2007, and conducted the biomarker analysis to evaluate how MDX-010 (now Ipilimumab) elicit clinical resposes in collaboration with MEDAREX and BMS. After going back to Japan at 2008, I continued to study basic cancer immunology (especially immunocheckpoint molecules and its clinical application) and phase I study of cancer immunotherapy for various solide tumors including melanoma and GI cancer by 2014. I changed my carrier focus to pharmaceutical industries, and initiated my carrie a Clincial Director in MSD Japan from 2015 and focused the clinical development, post-marketing studies, and the support of investigator-initiated studies for pembrolizumab (Keytruda). I moved to Bioverativ Japan from 2016 and served as a head of Medical to oversee all medical activities in the field of rare blood disorders, and then I served as Head of Oncology Medical in AstraZeneca Japan and oversee the project and activities of about 80 members from 2018. My curent focusis to leverage core value of Medical through high-qualified evidence generation, scientific communcaiton, and medical education, by adding new innovative imperatives such as digital partnership, patient centric innovative activities and medical environmental shaping activities. My goal is to transform Medical Afairs into "visionary" medical organization, whcih serves as excellent scientific core to change mecical environments in strong align with internal division and external collaborators.
Masahisa Jinushi’s Current Industry Gilead Sciences
Masahisa
Jinushi’s Prior Industry
Gilead Sciences
|
大阪大学
|
Dana Farber Cancer Institute
|
The University Of Tokyo
|
北海道大学
|
Msd
|
慶應義塾大学
|
Bioverativ A Sanofi
|
Astrazeneca
Not the Masahisa Jinushi you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience

Gilead Sciences
Country Medical Director, Head Of Medical Affairs, Japan
Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Astrazeneca
Head Of Oncology Medical
Fri Jun 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Oct 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Bioverativ A Sanofi
Executive Director, Head Of Medical Japan
Thu Dec 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Msd
Director, Head Of Oncology Scientific Affairs
Fri Jan 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Nov 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
慶應義塾大学
Adjunct Associate Professor
Wed Apr 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Msd
Director, Clinical Development Of Oncology
Thu Jan 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Jan 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
北海道大学
Associate Professor
Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Dec 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
The University Of Tokyo
Assistant Professor
Mon Oct 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Aug 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Dana Farber Cancer Institute
Research Associate
Thu Apr 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Sep 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
大阪大学
Medical Doctor
Tue Apr 01 1997 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Mar 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Gilead Sciences
Country Medical Director, Head of Medical Affairs, Japan
— Present